Literature DB >> 16491128

Siva-1 negatively regulates NF-kappaB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD).

R Gudi1, J Barkinge, S Hawkins, F Chu, S Manicassamy, Z Sun, J S Duke-Cohan, K V S Prasad.   

Abstract

Ligation of TCRs on stimulated T cells leads to activation-induced cell death (AICD) resulting in the downregulation of immune responses, a process essential for T-cell homeostasis. In this study, using transformed T-cell lines such as Jurkat and Do11.10 as cellular models of TCR-mediated AICD, we have demonstrated that the proapoptotic protein Siva-1 is required for TCR-induced apoptosis. Knockdown of Siva-1 rendered T cells specifically resistant to anti-CD3 but not Fas-induced apoptosis. Further, we observed that in Siva-1 knockout Jurkat cells, TCR-mediated activation of the canonical and non-canonical limbs of the NF-kappaB pathway are significantly enhanced as reflected by elevated nuclear levels of p65 and RelB, respectively. In addition, loss of endogenous Siva-1 also resulted in the enhanced expression of NF-kappaB- responsive anti-apoptotic genes such as Bcl-xL and c-FLIP. Interestingly, the c-FLIP(short) was detected only in TCR-ligated Siva-1 knockdown Jurkat cells. These results demonstrate a significant role for endogenous Siva-1, through its inhibitory effect on NF-kappaB activity, in TCR-mediated AICD with implications in peripheral tolerance, T-cell homeostasis and cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491128     DOI: 10.1038/sj.onc.1209381

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

Review 1.  Multifaceted functions of Siva-1: more than an Indian God of Destruction.

Authors:  Yide Mei; Mian Wu
Journal:  Protein Cell       Date:  2012-03-17       Impact factor: 14.870

2.  p53 target Siva regulates apoptosis in ischemic kidneys.

Authors:  Kurinji Singaravelu; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-09

3.  Siva plays a critical role in mouse embryonic development.

Authors:  Suzanne B R Jacobs; Jeanine L Van Nostrand; Margot E Bowen; Julie C Baker; Laura D Attardi
Journal:  Cell Death Differ       Date:  2019-06-04       Impact factor: 15.828

4.  The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury.

Authors:  Wenlin Deng; E Shuyu; Ryoko Tsukahara; William J Valentine; Gangadhar Durgam; Veeresa Gududuru; Louisa Balazs; Venkatraman Manickam; Marcello Arsura; Lester VanMiddlesworth; Leonard R Johnson; Abby L Parrill; Duane D Miller; Gabor Tigyi
Journal:  Gastroenterology       Date:  2007-03-24       Impact factor: 22.682

5.  Siva-1 promotes K-48 polyubiquitination of TRAF2 and inhibits TCR-mediated activation of NF-kappaB.

Authors:  Radhika Gudi; John Barkinge; Sarah Hawkins; Bellur Prabhakar; Prasad Kanteti
Journal:  J Environ Pathol Toxicol Oncol       Date:  2009       Impact factor: 3.567

6.  The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival.

Authors:  Fang-Tsyr Lin; Yun-Ju Lai; Natalia Makarova; Gabor Tigyi; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2007-10-26       Impact factor: 5.157

Review 7.  Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions.

Authors:  Fang-Tsyr Lin; Yun-Ju Lai
Journal:  Biochim Biophys Acta       Date:  2008-05-03

8.  Regulation of IL-2 gene expression by Siva and FOXP3 in human T cells.

Authors:  Virginia K Hench; Lishan Su
Journal:  BMC Immunol       Date:  2011-09-28       Impact factor: 3.615

9.  OKVAR-Boost: a novel boosting algorithm to infer nonlinear dynamics and interactions in gene regulatory networks.

Authors:  Néhémy Lim; Yasin Senbabaoglu; George Michailidis; Florence d'Alché-Buc
Journal:  Bioinformatics       Date:  2013-04-10       Impact factor: 6.937

10.  Transcriptome analysis of newt lens regeneration reveals distinct gradients in gene expression patterns.

Authors:  Konstantinos Sousounis; Mario Looso; Nobuyasu Maki; Clifford J Ivester; Thomas Braun; Panagiotis A Tsonis
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.